Smallcap investors look away: Over 600 stocks deliver double-digit negative returns already in 2026

The pain in India's smallcap space is no longer confined to a handful of overheated names. Barely weeks into 2026, more than 600 smallcap stocks have already slipped into double-digit negative returns, showing how deep and prolonged the correction in the broader market has become. For investors who rode the euphoric rally of 2023 and early 2024, the reversal has been sharp.

This correction has been building for nearly a year. After a strong run driven by liquidity, retail participation and optimism around India's growth story, the market began to split downwards. Largecaps, supported by stronger balance sheets, predictable earnings and institutional support, have largely weathered the storm since the last one year.

Smallcaps and microcaps, however, have struggled to hold ground as earnings momentum slowed and valuations came under pressure. In 2025, largecap investors managed gains of around 11% during the year, aided by improving fundamentals and clearer earnings visibility.


Midcaps, after delivering outsized returns of 44.6% in 2023 and 24.5% in 2024, still eked out gains of about 5-6% in 2025, even as volatility picked up. Forward valuations for midcaps moderated to about 27.8 times, while earnings growth and revisions continued to run above 20%, helping anchor returns.

Smallcaps, however, failed to keep pace. The smallcap index ended 2025 with losses of about 7%, while microcaps fared even worse, falling nearly 19%. What initially looked like a healthy consolidation has now stretched into a broader selloff that is looking increasingly worrying for investors.

It has been a one-way fall for the smallcap index since the start of November last year. At the index level, small caps are down over 11.5% since then. That alone looks painful, but the reality beneath the surface is far worse. Even in the current month, from January, the smallcap index has fallen by over 7%.

Several well known smallcap names are already nursing deep cuts this year. Shares of Kiri Industries are down nearly 35%, while Balu Forge Industries has lost over 33%. Systematix Corporate Services has fallen more than 31%, and Lotus Chocolate Company is lower by around 31%.

Other stocks such as Genesys International Corporation, Worth Investment and Trading, Allied Blenders, Nectar Lifesciences, Gujarat Themis Biosyn, Amal, Sai Silks (Kalamandir) and Cupid have all declined between 27% and 30% in just a few weeks of 2026.

Is this becoming increasingly worse for investors

Analysts say the correction is no longer just about excess valuations. Earnings growth and revisions in the broader market have been weak, making broad-based participation risky. Many smaller companies that benefitted from easy liquidity and optimistic growth assumptions are now facing tougher questions around profitability, cash flows and balance-sheet strength. In this environment, even modest disappointments are being punished swiftly.

Technical indicators also point to continued pressure. Emkay Global notes that both midcap and smallcap indices remain relatively weak, reflecting sideways-to-bearish undertones.

"The Nifty Midcap 150 is trading in a sideways-to-negative trend, with immediate support seen between 21,800 and 21,600. As long as the index remains below 22,000, it is likely to stay under pressure. The Nifty Smallcap 250 is moving within a falling channel and is hovering near a crucial base around 16,000," the broker said.

A decisive break below this level could intensify selling and drag the index toward 15,400, highlighting the risks that still linger in the broader market.

"Valuations remain meaningfully above historical averages. Before this correction, the smallcap index was trading at around 28–30x trailing earnings. Post the fall, valuations have moderated to about 25–26x, but this is still a huge premium to long-term averages. So at a broader market level, small and mid caps continue to look expensive, and it would be naïve to rule out more pain in the space," said ArunaGiri, CEO of TrustLine Holdings.

Despite the gloom, fund managers are not uniformly bearish on the medium-term outlook. Sunil Sharma, Chief Investment Strategist at Ambit Global Private Client, believes the key challenge for investors is weak earnings growth and limited upward revisions, which make indiscriminate exposure to smallcaps dangerous.

His outlook for 2026 is built around selectivity as bottom up investing through experienced fund managers is seen to outperform.

V Srivatsa, Executive Vice President and Fund Manager at UTI AMC, also sees the valuation gap between largecaps and smaller stocks as an important factor for 2026. Mid and smallcap indices continue to trade at a premium to largecaps, and Srivatsa believes this premium will matter as investors reassess risk.

In his view, largecaps are better placed to lead any recovery, given their valuation comfort, stronger balance sheets and more predictable earnings streams. While smaller stocks may bounce back selectively, leadership is likely to remain with companies that offer scale, financial strength and visibility.

Others argue that the current phase, while painful, could reset expectations in a healthier way. After a bruising 2025 and a weak start to 2026, the narrative around smallcaps is shifting from momentum-driven optimism to discipline and quality.

CA Anupam Tiwari, Head of Equity and a founding member at Groww Mutual Fund, believes 2026 could still turn out to be more constructive for smallcaps, but not through the kind of broad-based rallies seen in earlier years. Instead, he expects returns to be driven by bottom-up stock selection, balance-sheet discipline and companies that can deliver quality-led growth.

ArunaGiri said, at the stock-specific level, for truly bottom-up and selective investors, many compelling opportunities are emerging across small and mid caps, provided one is extremely choosy. In that sense, this is not a universal buy-on-dips market, nor is it a market to completely stay out of.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)